NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Zimmer Biomet announced a quarterly dividend on Tuesday, September 3rd. Shareholders of record on Monday, September 30th will be given a dividend of $0.24 per share on Thursday, October 31st. This represents a $0.96 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Friday, September 27th. View Zimmer Biomet's Dividend History.

Zimmer Biomet Holdings Inc (NYSE:ZBH) posted its quarterly earnings results on Tuesday, November, 5th. The medical equipment provider reported $1.77 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.75 by $0.02. The medical equipment provider earned $1.89 billion during the quarter, compared to analysts' expectations of $1.87 billion. Zimmer Biomet had a positive return on equity of 13.71% and a negative net margin of 1.14%. The company's quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.63 earnings per share. View Zimmer Biomet's Earnings History.

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Friday, February 7th 2020. View Earnings Estimates for Zimmer Biomet.

Zimmer Biomet updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $7.75 -7.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.82. The company issued revenue guidance of flat to +0.5% to ~$7.9-8.3 billion, compared to the consensus revenue estimate of $7.95 billion.

23 Wall Street analysts have issued 1 year price objectives for Zimmer Biomet's shares. Their forecasts range from $108.00 to $170.00. On average, they anticipate Zimmer Biomet's share price to reach $147.60 in the next year. This suggests a possible upside of 0.4% from the stock's current price. View Analyst Price Targets for Zimmer Biomet.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 4 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

News articles about ZBH stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Zimmer Biomet earned a daily sentiment score of -1.1 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Zimmer Biomet.

Some companies that are related to Zimmer Biomet include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), COLOPLAST A/S/ADR (CLPBY), Align Technology (ALGN), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Wound Management Technologies (WNDM), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN) and Invacare (IVC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Celgene (CELG), Bristol-Myers Squibb (BMY), Chevron (CVX), Walt Disney (DIS), Visa (V) and Intel (INTC).

Zimmer Biomet's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (5.38%), State Street Corp (4.04%), Boston Partners (1.88%), Wedge Capital Management L L P NC (0.47%), Focused Investors LLC (0.45%) and Sumitomo Mitsui Trust Holdings Inc. (0.39%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

ZBH stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Squarepoint Ops LLC, Man Group plc, Focused Investors LLC, Wedge Capital Management L L P NC, State of New Jersey Common Pension Fund D, State Street Corp and Rothschild Investment Corp IL. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

ZBH stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., California Public Employees Retirement System, Deroy & Devereaux Private Investment Counsel Inc., Voya Investment Management LLC, Douglas Lane & Associates LLC, Tamarack Advisers LP, Parametric Portfolio Associates LLC and Endurant Capital Management LP. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ZBH stock can currently be purchased for approximately $147.01.

Zimmer Biomet has a market capitalization of $30.24 billion and generates $7.93 billion in revenue each year. The medical equipment provider earns $-379,200,000.00 in net income (profit) each year or $7.64 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]